KEAP1 and cancer: High expression of Nrf2 in human cancer cells can due to somatic mutations in Keap1 or Nrf2, epigenetic silencing of Keap1, transcriptional upregulation of oncogene signaling related to Nrf2 and aggregation of Nrf2/Keap1 complex disrupting proteins (24).